单克隆抗体生物类似药、生物改良药以及创新单抗的研发及产业化
Includes 165 companies , followed by 44 people
Includes 42 companies , followed by 15 people
Includes 29 companies , followed by 2 people
Includes 68 companies , followed by 1 people
Includes 27 companies